193 related articles for article (PubMed ID: 31616442)
1. Loss of TIPE2 Has Opposing Effects on the Pathogenesis of Autoimmune Diseases.
Liu R; He X; Geng W; Wang T; Ruan Q
Front Immunol; 2019; 10():2284. PubMed ID: 31616442
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the Reactive Oxygen Response Alleviates Experimental Autoimmune Uveitis in Mice.
Hsu SM; Yang CH; Teng YT; Tsai HY; Lin CY; Lin CJ; Shieh CC; Chen SH
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380695
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.
Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K
J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321
[TBL] [Abstract][Full Text] [Related]
4. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
[TBL] [Abstract][Full Text] [Related]
5. Key role for IL-21 in experimental autoimmune uveitis.
Wang L; Yu CR; Kim HP; Liao W; Telford WG; Egwuagu CE; Leonard WJ
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9542-7. PubMed ID: 21593413
[TBL] [Abstract][Full Text] [Related]
6. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2⁻/⁻CX₃CR1gfp/gfp mice.
Zhao J; Chen M; Xu H
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7572-82. PubMed ID: 25342612
[TBL] [Abstract][Full Text] [Related]
7. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
[TBL] [Abstract][Full Text] [Related]
8. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
Haq E; Rohrer B; Nath N; Crosson CE; Singh I
J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulatory role of ocular macrophages: the macrophages produce RANTES to suppress experimental autoimmune uveitis.
Sonoda KH; Sasa Y; Qiao H; Tsutsumi C; Hisatomi T; Komiyama S; Kubota T; Sakamoto T; Kawano Y; Ishibashi T
J Immunol; 2003 Sep; 171(5):2652-9. PubMed ID: 12928419
[TBL] [Abstract][Full Text] [Related]
10. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis.
Yoshimura T; Sonoda KH; Miyazaki Y; Iwakura Y; Ishibashi T; Yoshimura A; Yoshida H
Int Immunol; 2008 Feb; 20(2):209-14. PubMed ID: 18156624
[TBL] [Abstract][Full Text] [Related]
11. Critical roles of TIPE2 protein in murine experimental colitis.
Lou Y; Sun H; Morrissey S; Porturas T; Liu S; Hua X; Chen YH
J Immunol; 2014 Aug; 193(3):1064-70. PubMed ID: 24973456
[TBL] [Abstract][Full Text] [Related]
12. Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response.
Wandu WS; Tan C; Ogbeifun O; Vistica BP; Shi G; Hinshaw SJ; Xie C; Chen X; Klinman DM; Cai H; Gery I
PLoS One; 2015; 10(6):e0128906. PubMed ID: 26067490
[TBL] [Abstract][Full Text] [Related]
13. Effects of experimental ocular inflammation on ocular immune privilege.
Ohta K; Wiggert B; Taylor AW; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
[TBL] [Abstract][Full Text] [Related]
14. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis.
Sun H; Gong S; Carmody RJ; Hilliard A; Li L; Sun J; Kong L; Xu L; Hilliard B; Hu S; Shen H; Yang X; Chen YH
Cell; 2008 May; 133(3):415-26. PubMed ID: 18455983
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous development of autoimmune uveitis Is CCR2 dependent.
Chen YF; Zhou D; Metzger T; Gallup M; Jeanne M; Gould DB; Anderson MS; McNamara NA
Am J Pathol; 2014 Jun; 184(6):1695-705. PubMed ID: 24736166
[TBL] [Abstract][Full Text] [Related]
16. Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity.
Su SB; Silver PB; Grajewski RS; Agarwal RK; Tang J; Chan CC; Caspi RR
J Immunol; 2005 Nov; 175(10):6303-10. PubMed ID: 16272281
[TBL] [Abstract][Full Text] [Related]
17. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory processes triggered by TCR engagement or by local cytokine expression: differences in profiles of gene expression and infiltrating cell populations.
Takase H; Yu CR; Ham DI; Chan CC; Chen J; Vistica BP; Wawrousek EF; Durum SK; Egwuagu CE; Gery I
J Leukoc Biol; 2006 Sep; 80(3):538-45. PubMed ID: 16793919
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis.
Yoshimura T; Sonoda KH; Ohguro N; Ohsugi Y; Ishibashi T; Cua DJ; Kobayashi T; Yoshida H; Yoshimura A
Rheumatology (Oxford); 2009 Apr; 48(4):347-54. PubMed ID: 19164426
[TBL] [Abstract][Full Text] [Related]
20. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
